United States · 
Who invested in MicroPure Genomics?
MicroPure Genomics's investors include National Science Foundation, National Institutes of Health and EvoNexus.
2026
$300KGrant$675KRound
United States · Funded startup
Who invested in MicroPure Genomics
Funding summaryUpdated 26 Oct 2026
$975Kraised across 2 rounds since 2025, from 2 sources
$300KGrant$675KRound
- Latest round
- Round, $675KJul 2026
- Step-upi
- 2.3×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $300K Sept 2025
- Biggest round
- $675K Round · Jul 2026
- Between rounds
- 10 months from the last two
The rounds
- Jul 2026Round$675K
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $675K sold, first sale Jul 2026
- Sept 2025
Founders and team
From MicroPure Genomics's own website: 2 founders, 3 on the team.
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about MicroPure Genomics
How much has MicroPure Genomics raised?
MicroPure Genomics has raised $975K across 2 rounds since 2025.
When did MicroPure Genomics last raise?
MicroPure Genomics's most recent round, $675K, was in Jul 2026.
What was MicroPure Genomics's biggest round?
Its most recent round, $675K in Jul 2026, is also its largest on record.
Who backed MicroPure Genomics first?
MicroPure Genomics's first round on record, in Sept 2025, was backed by National Science Foundation, National Institutes of Health and EvoNexus.
What stage is MicroPure Genomics at?
MicroPure Genomics's latest named round is a Grant, in Sept 2025.
Where is MicroPure Genomics based?
MicroPure Genomics is based in the United States.
Companies like MicroPure Genomics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.